American Journal of Ophthalmology
Volume 139, Issue 4 , Pages 589-596 , April 2005

Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration

  • Ruxandra Hera, MD

      Affiliations

    • Department of Opthalmology, University Hospital of Grenoble, La Tronche, France
    • INSERM EMI 01–05, Department of Cell Responses and Dynamics, Commissariat á l’Energie Atomique, Grenoble, France
    • Ruxandra Hera and Michelle Keramidas contributed equally to this work.
  • ,
  • Michelle Keramidas, MSc

      Affiliations

    • INSERM EMI 01–05, Department of Cell Responses and Dynamics, Commissariat á l’Energie Atomique, Grenoble, France
    • Ruxandra Hera and Michelle Keramidas contributed equally to this work.
  • ,
  • Michel Peoc’h, MD

      Affiliations

    • Department of Pathology, University Hospital of Grenoble, La Tronche, France
  • ,
  • Michel Mouillon, MD

      Affiliations

    • Department of Opthalmology, University Hospital of Grenoble, La Tronche, France
  • ,
  • Jean-Paul Romanet, MD

      Affiliations

    • Department of Opthalmology, University Hospital of Grenoble, La Tronche, France
  • ,
  • Jean-Jacques Feige, PhD

      Affiliations

    • INSERM EMI 01–05, Department of Cell Responses and Dynamics, Commissariat á l’Energie Atomique, Grenoble, France
    • Corresponding Author InformationInquiries to Dr J. J. Feige, INSERM EMI 01-05, DRDC/ANGIO, CEA-G, 17 Rue des Martyrs, 38054 Grenoble Cedex 9, France; fax: (33) 438-785-058

,Accepted 29 November 2004.

References 

  1. la Cour M , Kiilgaard JF , Nissen MH . Age-related macular degeneration (epidemiology and optimal treatment) . Drugs Aging . 2002;19:101–133
  2. Klein R , Peto T , Bird A , Vannewkirk MR . The epidemiology of age-related macular degeneration . Am J Ophthalmol . 2004;137:486–495
  3. Ambati J , Ambati BK , Yoo SH , Ianchulev S , Adamis AP . Age-related macular degeneration (etiology, pathogenesis, and therapeutic strategies) . Surv Ophthalmol . 2003;48:257–293
  4. Young RW . Solar radiation and age-related macular degeneration . Surv Ophthalmol . 1988;32:252–269
  5. Young RW . Pathophysiology of age-related macular degeneration . Surv Ophthalmol . 1987;31:291–306
  6. Lip PL , Blann AD , Hope-Ross M , Gibson JM , Lip GY . Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction . Ophthalmology . 2001;108:705–710
  7. Seddon J , Chen C . The epidemiology of age related macular degeneration . In:  Heier J editors. Controversies and advancement in the treatment of retinal disease . Philadelphia: Lippincott Williams & Wilkins; 2004;p. 17–39
  8. Ferrara N , Gerber HP , LeCouter J . The biology of VEGF and its receptors . Nat Med . 2003;9:669–676
  9. Davis S , Yancopoulos GD . The angiopoietins (yin and yang in angiogenesis) . Curr Top Microbiol Immunol . 1999;237:173–185
  10. Soker S , Takashima S , Miao HQ , Neufeld G , Klagsbrun M . Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor . Cell . 1998;92:735–745
  11. Soker S , Miao HQ , Nomi M , Takashima S , Klagsbrun M . VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding . J Cell Biochem . 2002;85:357–368
  12. Holash J , Wiegand SJ , Yancopoulos GD . New model of tumor angiogenesis (dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF) . Oncogene . 1999;18:5356–5362
  13. Frank RN , Amin RH , Eliott D , Puklin JE , Abrams GW . Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes . Am J Ophthalmol . 1996;122:393–403
  14. Kvanta A , Algvere PV , Berglin L , Seregard S . Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor . Invest Ophthalmol Vis Sci . 1996;37:1929–1934
  15. Otani A , Takagi H , Oh H , Koyama S , Matsumura M , Honda Y . Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes . Invest Ophthalmol Vis Sci . 1999;40:1912–1920
  16. McLeod DS , Taomoto M , Otsuji T , Green WR , Sunness JS , Lutty GA . Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration . Invest Ophthalmol Vis Sci . 2002;43:1986–1993
  17. Lopez PF , Sippy BD , Lambert HM , Thach AB , Hinton DR . Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes . Invest Ophthalmol Vis Sci . 1996;37:855–868
  18. Adamis AP , Miller JW , Bernal MT , et al.   Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy . Am J Ophthalmol . 1994;118:445–450
  19. Alon T , Hemo I , Itin A , Pe’er J , Stone J , Keshet E . Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity . Nat Med . 1995;1:1024–1028
  20. Tripathi RC , Li J , Tripathi BJ , Chalam KV , Adamis AP . Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma . Ophthalmology . 1998;105:232–237
  21. Krzystolik MG , Afshari MA , Adamis AP , et al.   Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment . Arch Ophthalmol . 2002;120:338–346
  22. Garrett KL , Shen WY , Rakoczy PE . In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye . J Gene Med . 2001;3:373–383
  23. Otani A , Takagi H , Oh H , Koyama S , Matsumura M , Honda Y . Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes . Invest Ophthalmol Vis Sci . 1999;40:1912–1920
  24. Shweiki D , Itin A , Neufeld G , Gitay-Goren H , Keshet E . Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis . J Clin Invest . 1993;91:2235–2243
  25. Gupta K , Kshirsagar S , Li W , et al.   VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling . Exp Cell Res . 1999;247:495–504
  26. Benjamin LE , Hemo I , Keshet E . A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF . Development . 1998;125:1591–1598
  27. Upalakalin JN , Hemo I , Dehio C , Keshet E , Benjamin LE . Survival mechanisms of VEGF and PlGF during microvascular remodeling . Cold Spring Harb Symp Quant Biol . 2002;67:181–187
  28. Koyama R , Nakanishi T , Ikeda T , Shimizu A . Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors . J Chromatogr B Analyt Technol Biomed Life Sci . 2003;792:5–21
  29. Holekamp NM , Bouck N , Volpert O . Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration . Am J Ophthalmol . 2002;134:220–227
  30. Sheibani N , Sorenson CM , Cornelius LA , Frazier WA . Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia . Biochem Biophys Res Commun . 2000;267:257–261
  31. Iruela-Arispe ML , Dvorak HF . Angiogenesis (a dynamic balance of stimulators and inhibitors) . Thromb Haemost . 1997;78:672–677

 This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM EMI 01–05) and by the University Joseph Fourier (UFR Médecine).

PII: S0002-9394(04)01463-1

doi: 10.1016/j.ajo.2004.11.064

American Journal of Ophthalmology
Volume 139, Issue 4 , Pages 589-596 , April 2005